MODIFICATION TO ABUSCREEN ONLINE FOR CANNABINOIDS

Enzyme Immunoassay, Cannabinoids

ROCHE DIAGNOSTIC SYSTEMS, INC.

The following data is part of a premarket notification filed by Roche Diagnostic Systems, Inc. with the FDA for Modification To Abuscreen Online For Cannabinoids.

Pre-market Notification Details

Device IDK983701
510k NumberK983701
Device Name:MODIFICATION TO ABUSCREEN ONLINE FOR CANNABINOIDS
ClassificationEnzyme Immunoassay, Cannabinoids
Applicant ROCHE DIAGNOSTIC SYSTEMS, INC. BRANCHBURG TOWNSHIP 1080 U.S. HIGHWAY 202 Somerville,  NJ  08876 -3771
ContactRita Smith
CorrespondentRita Smith
ROCHE DIAGNOSTIC SYSTEMS, INC. BRANCHBURG TOWNSHIP 1080 U.S. HIGHWAY 202 Somerville,  NJ  08876 -3771
Product CodeLDJ  
CFR Regulation Number862.3870 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received1998-10-21
Decision Date1998-12-11
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.